(META) Meta Platforms - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US30303M1027
Stock: Social Media Apps, Virtual Reality, Augmented Reality, Mixed Reality, Wearables
Total Rating 58
Risk 93
Buy Signal -0.87
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.31% |
| Yield on Cost 5y | 0.79% |
| Yield CAGR 5y | 5.00% |
| Payout Consistency | 100.0% |
| Payout Ratio | 5.6% |
| Risk 5d forecast | |
|---|---|
| Volatility | 38.3% |
| Relative Tail Risk | -9.19% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.08 |
| Alpha | -20.15 |
| Character TTM | |
|---|---|
| Beta | 1.416 |
| Beta Downside | 1.450 |
| Drawdowns 3y | |
|---|---|
| Max DD | 34.15% |
| CAGR/Max DD | 1.59 |
Description: META Meta Platforms January 27, 2026
Meta Platforms, Inc. (NASDAQ:META) develops a suite of social and communication products-including Facebook, Instagram, Messenger, Threads, and WhatsApp-under its Family of Apps (FoA) segment, while its Reality Labs (RL) segment focuses on consumer hardware, software, and content for virtual, augmented, and mixed reality experiences.
Key recent metrics: Q4 2023 revenue reached $36.3 billion, driven by a 7% year-over-year rise in advertising spend; the company reported 3.1 billion monthly active users across its apps, with Instagram contributing 2 billion MAUs; RL’s capital outlay hit $3.7 billion for the year, reflecting Meta’s bet on the expanding $300 billion AR/VR market projected to grow at ~15% CAGR through 2030.
Macro drivers shaping Meta’s outlook include resilient global digital ad budgets, the gradual shift of advertisers toward short-form video (reels, stories), and the competitive race to monetize immersive platforms as consumer adoption of headsets accelerates.
For a deeper quantitative view, explore the ValueRay dashboard to see how these trends translate into valuation signals.
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income: 60.46b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.13 > 0.02 and ΔFCF/TA -6.99 > 1.0 |
| NWC/Revenue: 33.28% < 20% (prev 40.39%; Δ -7.11% < -1%) |
| CFO/TA 0.32 > 3% & CFO 115.80b > Net Income 60.46b |
| Net Debt (48.02b) to EBITDA (105.96b): 0.45 < 3 |
| Current Ratio: 2.60 > 1.5 & < 3 |
| Outstanding Shares: last quarter (2.57b) vs 12m ago -1.53% < -2% |
| Gross Margin: 82.00% > 18% (prev 0.82%; Δ 8118 % > 0.5%) |
| Asset Turnover: 62.60% > 50% (prev 59.59%; Δ 3.01% > 0%) |
| Interest Coverage Ratio: 61.69 > 6 (EBITDA TTM 105.96b / Interest Expense TTM 1.42b) |
Altman Z'' 4.96
| A: 0.18 (Total Current Assets 108.72b - Total Current Liabilities 41.84b) / Total Assets 366.02b |
| B: 0.33 (Retained Earnings 121.18b / Total Assets 366.02b) |
| C: 0.27 (EBIT TTM 87.35b / Avg Total Assets 321.04b) |
| D: 0.82 (Book Value of Equity 121.45b / Total Liabilities 148.78b) |
| Altman-Z'' Score: 4.96 = AAA |
Beneish M -2.98
| DSRI: 0.95 (Receivables 19.77b/16.99b, Revenue 200.97b/164.50b) |
| GMI: 1.00 (GM 82.00% / 81.66%) |
| AQI: 1.15 (AQ_t 0.17 / AQ_t-1 0.14) |
| SGI: 1.22 (Revenue 200.97b / 164.50b) |
| TATA: -0.15 (NI 60.46b - CFO 115.80b) / TA 366.02b) |
| Beneish M-Score: -2.98 (Cap -4..+1) = A |
What is the price of META shares?
As of February 04, 2026, the stock is trading at USD 691.70 with a total of 13,753,465 shares traded.
Over the past week, the price has changed by +2.78%, over one month by +5.00%, over three months by +8.55% and over the past year by -0.51%.
Over the past week, the price has changed by +2.78%, over one month by +5.00%, over three months by +8.55% and over the past year by -0.51%.
Is META a buy, sell or hold?
Meta Platforms has received a consensus analysts rating of 4.54.
Therefore, it is recommended to buy META.
- StrongBuy: 47
- Buy: 13
- Hold: 6
- Sell: 2
- StrongSell: 0
What are the forecasts/targets for the META price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 848.1 | 22.6% |
| Analysts Target Price | 848.1 | 22.6% |
| ValueRay Target Price | 914.2 | 32.2% |
META Fundamental Data Overview January 31, 2026
P/E Trailing = 30.7928
P/E Forward = 24.8139
P/S = 9.1022
P/B = 8.5968
P/EG = 1.7456
Revenue TTM = 200.97b USD
EBIT TTM = 87.35b USD
EBITDA TTM = 105.96b USD
Long Term Debt = 28.83b USD (from longTermDebt, two quarters ago)
Short Term Debt = 2.21b USD (from shortTermDebt, last quarter)
Debt = 83.90b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 48.02b USD (from netDebt column, last quarter)
Enterprise Value = 1831.21b USD (1828.91b + Debt 83.90b - CCE 81.59b)
Interest Coverage Ratio = 61.69 (Ebit TTM 87.35b / Interest Expense TTM 1.42b)
EV/FCF = 39.71x (Enterprise Value 1831.21b / FCF TTM 46.11b)
FCF Yield = 2.52% (FCF TTM 46.11b / Enterprise Value 1831.21b)
FCF Margin = 22.94% (FCF TTM 46.11b / Revenue TTM 200.97b)
Net Margin = 30.08% (Net Income TTM 60.46b / Revenue TTM 200.97b)
Gross Margin = 82.00% ((Revenue TTM 200.97b - Cost of Revenue TTM 36.17b) / Revenue TTM)
Gross Margin QoQ = 81.79% (prev 82.03%)
Tobins Q-Ratio = 5.00 (Enterprise Value 1831.21b / Total Assets 366.02b)
Interest Expense / Debt = 0.84% (Interest Expense 708.0m / Debt 83.90b)
Taxrate = 10.20% (2.58b / 25.35b)
NOPAT = 78.44b (EBIT 87.35b * (1 - 10.20%))
Current Ratio = 2.60 (Total Current Assets 108.72b / Total Current Liabilities 41.84b)
Debt / Equity = 0.39 (Debt 83.90b / totalStockholderEquity, last quarter 217.24b)
Debt / EBITDA = 0.45 (Net Debt 48.02b / EBITDA 105.96b)
Debt / FCF = 1.04 (Net Debt 48.02b / FCF TTM 46.11b)
Total Stockholder Equity = 197.85b (last 4 quarters mean from totalStockholderEquity)
RoA = 18.83% (Net Income 60.46b / Total Assets 366.02b)
RoE = 30.56% (Net Income TTM 60.46b / Total Stockholder Equity 197.85b)
RoCE = 38.53% (EBIT 87.35b / Capital Employed (Equity 197.85b + L.T.Debt 28.83b))
RoIC = 35.62% (NOPAT 78.44b / Invested Capital 220.22b)
WACC = 10.68% (E(1828.91b)/V(1912.80b) * Re(11.13%) + D(83.90b)/V(1912.80b) * Rd(0.84%) * (1-Tc(0.10)))
Discount Rate = 11.13% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.07%
[DCF Debug] Terminal Value 71.05% ; FCFF base≈49.29b ; Y1≈55.43b ; Y5≈74.21b
Fair Price DCF = 358.7 (EV 832.47b - Net Debt 48.02b = Equity 784.45b / Shares 2.19b; r=10.68% [WACC]; 5y FCF grow 14.46% → 2.90% )
EPS Correlation: 85.05 | EPS CAGR: 37.10% | SUE: 1.63 | # QB: 10
Revenue Correlation: 96.06 | Revenue CAGR: 22.59% | SUE: 1.75 | # QB: 3
EPS next Quarter (2026-03-31): EPS=6.57 | Chg30d=+0.244 | Revisions Net=+6 | Analysts=33
EPS current Year (2026-12-31): EPS=29.64 | Chg30d=+0.021 | Revisions Net=+5 | Growth EPS=+26.2% | Growth Revenue=+23.2%
EPS next Year (2027-12-31): EPS=34.17 | Chg30d=+0.923 | Revisions Net=+7 | Growth EPS=+15.3% | Growth Revenue=+16.2%
P/E Forward = 24.8139
P/S = 9.1022
P/B = 8.5968
P/EG = 1.7456
Revenue TTM = 200.97b USD
EBIT TTM = 87.35b USD
EBITDA TTM = 105.96b USD
Long Term Debt = 28.83b USD (from longTermDebt, two quarters ago)
Short Term Debt = 2.21b USD (from shortTermDebt, last quarter)
Debt = 83.90b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 48.02b USD (from netDebt column, last quarter)
Enterprise Value = 1831.21b USD (1828.91b + Debt 83.90b - CCE 81.59b)
Interest Coverage Ratio = 61.69 (Ebit TTM 87.35b / Interest Expense TTM 1.42b)
EV/FCF = 39.71x (Enterprise Value 1831.21b / FCF TTM 46.11b)
FCF Yield = 2.52% (FCF TTM 46.11b / Enterprise Value 1831.21b)
FCF Margin = 22.94% (FCF TTM 46.11b / Revenue TTM 200.97b)
Net Margin = 30.08% (Net Income TTM 60.46b / Revenue TTM 200.97b)
Gross Margin = 82.00% ((Revenue TTM 200.97b - Cost of Revenue TTM 36.17b) / Revenue TTM)
Gross Margin QoQ = 81.79% (prev 82.03%)
Tobins Q-Ratio = 5.00 (Enterprise Value 1831.21b / Total Assets 366.02b)
Interest Expense / Debt = 0.84% (Interest Expense 708.0m / Debt 83.90b)
Taxrate = 10.20% (2.58b / 25.35b)
NOPAT = 78.44b (EBIT 87.35b * (1 - 10.20%))
Current Ratio = 2.60 (Total Current Assets 108.72b / Total Current Liabilities 41.84b)
Debt / Equity = 0.39 (Debt 83.90b / totalStockholderEquity, last quarter 217.24b)
Debt / EBITDA = 0.45 (Net Debt 48.02b / EBITDA 105.96b)
Debt / FCF = 1.04 (Net Debt 48.02b / FCF TTM 46.11b)
Total Stockholder Equity = 197.85b (last 4 quarters mean from totalStockholderEquity)
RoA = 18.83% (Net Income 60.46b / Total Assets 366.02b)
RoE = 30.56% (Net Income TTM 60.46b / Total Stockholder Equity 197.85b)
RoCE = 38.53% (EBIT 87.35b / Capital Employed (Equity 197.85b + L.T.Debt 28.83b))
RoIC = 35.62% (NOPAT 78.44b / Invested Capital 220.22b)
WACC = 10.68% (E(1828.91b)/V(1912.80b) * Re(11.13%) + D(83.90b)/V(1912.80b) * Rd(0.84%) * (1-Tc(0.10)))
Discount Rate = 11.13% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.07%
[DCF Debug] Terminal Value 71.05% ; FCFF base≈49.29b ; Y1≈55.43b ; Y5≈74.21b
Fair Price DCF = 358.7 (EV 832.47b - Net Debt 48.02b = Equity 784.45b / Shares 2.19b; r=10.68% [WACC]; 5y FCF grow 14.46% → 2.90% )
EPS Correlation: 85.05 | EPS CAGR: 37.10% | SUE: 1.63 | # QB: 10
Revenue Correlation: 96.06 | Revenue CAGR: 22.59% | SUE: 1.75 | # QB: 3
EPS next Quarter (2026-03-31): EPS=6.57 | Chg30d=+0.244 | Revisions Net=+6 | Analysts=33
EPS current Year (2026-12-31): EPS=29.64 | Chg30d=+0.021 | Revisions Net=+5 | Growth EPS=+26.2% | Growth Revenue=+23.2%
EPS next Year (2027-12-31): EPS=34.17 | Chg30d=+0.923 | Revisions Net=+7 | Growth EPS=+15.3% | Growth Revenue=+16.2%